Prof Dr. bing han | Medicinal Chemistry | Outstanding Scientist Award

Prof Dr. bing han, Peking University School and Hospital of Stomatology, China

Professional Profiles

🎓 Academic Qualifications

Professor Bing Han’s academic journey began at Peking University where he completed his Consecutive Degree Program (Bachelor and MD) at the School of Stomatology from 1997 to 2004. He then pursued a Ph.D. at the same institution, graduating in 2007. His education laid the foundation for a highly successful career in orthodontics and craniofacial research.

🏆 Professional Achievements

Professor Han’s dedication to advancing the field of orthodontics is evident through his prestigious roles and recognition. In 2021, he was named a Leading Talent of Science and Technology Innovation under the National Ten Thousand Talents Plan. His current role as Professor and Vice Director of the Department of Orthodontics at Peking University School and Hospital of Stomatology has been ongoing since 2018. Previously, he served as an Associate Professor (2012-2018) and held the role of Lecturer and Doctor in Charge from 2007 to 2012.

🔬 Research Interests and Contributions

Professor Bing Han has conducted pioneering research in craniofacial growth and development, bone tissue engineering, stem cells, orthodontics, and biomaterials. His interdisciplinary approach blends clinical expertise with innovative research to address fundamental challenges in the field. His work has contributed significantly to the understanding of bone regeneration and the application of biomaterials in orthodontics, shaping advancements in both medical and dental sciences.

🏅 Honors and Awards

Professor Bing Han has received numerous prestigious accolades in recognition of his groundbreaking contributions to orthodontics, research, and education. He was honored under the National High-Level Talents Special Support Program as a Leading Talent of Technological Innovation, a testament to his influence in advancing dental sciences. Additionally, he was selected for the Innovation Leadership Program for Young and Middle-aged Scientists, showcasing his role as a visionary in scientific research and technology.

Among his notable achievements, Professor Han was awarded the Prize for Outstanding Doctor of Peking University, reflecting his excellence in both clinical practice and academia. His innovative work has also been recognized with the Second Prize of the Beijing Science and Technology Award and the Second Prize of the Chinese Stomatology Science and Technology Award, further solidifying his reputation as a leading figure in the field of orthodontics. These accolades underscore his exceptional dedication to advancing knowledge and improving clinical outcomes in stomatology.

Publications Top Noted📝

Recent Progress in the Auxiliary Phase Enhanced Flexible Piezocomposites

Authors: Gao, X., Zheng, M., Hou, B., Wang, K., Han, B.

Journal: Energy and Environmental Materials

Year: 2025

Dynamics of the Oral Microbiome During Orthodontic Treatment and Antimicrobial Advances for Orthodontic Appliances

Authors: Niu, Q., Chen, S., Bai, R., Han, B., Yu, T.

Journal: iScience

Year: 2024

Colon-Targeted Engineered Postbiotics Nanoparticles Alleviate Osteoporosis Through the Gut-Bone Axis

Authors: Yu, T., Bai, R., Wang, Z., Nie, G., Han, B.

Journal: Nature Communications

Year: 2024

Origin of Ultrahigh-Performance Barium Titanate-Based Piezoelectrics: Stannum-Induced Intrinsic and Extrinsic Contributions

Authors: Wu, B., Zheng, H., Wu, Y.-Q., Wang, K., Han, B.

Journal: Nature Communications

Year: 2024

Network Analysis of Three-Dimensional Hard-Soft Tissue Relationships in the Lower 1/3 of the Face: Skeletal Class I-Normodivergent Malocclusion Versus Class II-Hyperdivergent Malocclusion

Authors: Wang, T., Nie, K., Fan, Y., Song, G., Xu, T.

Journal: BMC Oral Health

Year: 2024

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Doctorate at CEA, France

Professional Profiles

Google Scholar

Scopus

Orcid

🎓 Educational Background

Dr. Aloïse Mabondzo, has a distinguished academic foundation. He earned his Master’s degree in Molecular and Cellular Biology from the University of Strasbourg, France (1986-1989). Driven by a passion for cutting-edge research, he pursued a PhD in Virology and Immunology at the prestigious Pierre and Marie Curie University, France (1989-1993). His doctoral work focused on Active Immunotherapy using bispecific antibodies against HIV, a testament to his early commitment to tackling global health challenges.

🧪 Professional Positions

Dr. Mabondzo’s illustrious career began with a Post-doctoral Research Fellowship (1993-1997) at the CEA Neurovirology Department, where he made significant contributions to the field of neurovirology. In 1998, he joined the CEA Medicine and Healthcare Technologies Department, where he has served as Research Director and Head of the Neurovascular Unit Research and Therapeutic Innovation Laboratory. His leadership in these roles has driven breakthroughs in neurovascular research. Since 2019, Dr. Mabondzo has also been the Co-founder and Research Director of Ceres Brain Therapeutics, a startup dedicated to pioneering therapeutic innovations.

👩‍🏫 Mentoring and Supervision

Dr. Mabondzo has a proven track record as a mentor and supervisor. Over his career, he has supervised 16 PhD candidates (10 past, 6 current), 7 Postdoctoral Fellows (4 past, 3 current), and several other researchers, including 2 Research Assistants, 2 Engineers, and 2 Technicians. His mentorship has nurtured the next generation of scientists, fostering innovation and collaboration.

Publications Top Noted📄

Dodecyl creatine ester therapy: from promise to reality

Authors: Mabondzo, A.; van de Kamp, J.; Mercimek-Andrews, S.

Journal: Cellular and Molecular Life Sciences

Year: 2024

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

Authors: Angeli, E.; Paris, J.; Le Tilly, O.; Paintaud, G.; Bousquet, G.

Journal: Experimental Hematology and Oncology

Year: 2024

Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model

Authors: Disdier, C.; Soyer, A.; Broca-Brisson, L.; Tournier, N.; Mabondzo, A.

Journal: Neurobiology of Disease

Year: 2024

Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

Authors: Maïza, A.; Hamoudi, R.; Mabondzo, A.

Journal: International Journal of Molecular Sciences

Year: 2024

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Authors: Broca-Brisson, L.; Disdier, C.; Harati, R.; Hamoudi, R.; Mabondzo, A.

Journal: Frontiers in Neuroscience

Year: 2024